Daiichi Sankyo

Astellas scores first US blood cancer approval with Xospata

https://pharmaphorum.com/news/astellas-scores-first-us-blood-cancer-approval-with-xospata/

FDA grants leukaemia drug ‘breakthrough’ status

https://pharmaphorum.com/market-access-2/fda-grants-leukaemia-drug-breakthrough-status/

ASCO 2018 – Monday 4th June: BMS tries different tack as Merck & Co locks out lung cancer I/O

https://pharmaphorum.com/event-coverage/asco-2018-bms-merck-co-locks-out-lung-cancer-i-o/

AZ tried to buy Daiichi Sankyo last year – report

https://pharmaphorum.com/news/az-tried-buy-daiichi-sankyo-last-year-report/

Daiichi Sankyo anticoagulant gains EU label boost

https://pharmaphorum.com/news/daiichi-sankyo-noac-get-eu-label-boost/

Nissan stays in UK – but will Japanese pharma?

https://pharmaphorum.com/news/nissan-stays-uk-will-japanese-pharma/

Close in 10 seconds

Pharmaphorum.com

Search